ZIPS Study - Zip Incision aPproximation vs. Suture
ZIPS
A Prospective, Non-blinded, Randomized Controlled Post-market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device Versus Conventional Sutures for Skin Closure in Subjects Who Undergo a CIED Procedure.
1 other identifier
interventional
40
1 country
1
Brief Summary
ZipLine Medical, Inc. has developed a novel, non-invasive skin closure device called "Zip Surgical Skin Closure" to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. The study will be comparing the Zip Surgical Skin Closure to standard sutures in patients undergoing cardiovascular implantable electronic device (CIED) procedures on outcomes including closure time, cosmetic appearance of resulting scar, and overall cosmetic appearance of scar. The study will be following participants for 3 months following CIED procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 7, 2014
CompletedFirst Posted
Study publicly available on registry
August 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedResults Posted
Study results publicly available
May 30, 2016
CompletedMay 30, 2016
May 1, 2016
10 months
August 7, 2014
February 29, 2016
May 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Overall Closure Time
Duration of time starting when suture needle (control) or Zip device touches the skin until final suture knot is cut or Zip device application is complete (e.g., top liner is removed.)
2 weeks
Wound Healing as Determined by the CVAS (Cosmetic Visual Analogue Scale)
Based on photographs taken of scars taken at 3 months following CIED procedure. The CVAS scale is measured from 0mm (representing best scar) to 100 mm (representing worst scar).
3 Months
Secondary Outcomes (9)
Surgeon Wound Evaluation Scale (WES)
2 weeks
Surgeon Evaluation Based on the Wound Evaluation Scale (WES)
3 Months
Surgeon Satisfaction With Scar
3 months
Patient Comfort
2 weeks
Patient Satisfaction With Scar
3 months
- +4 more secondary outcomes
Study Arms (2)
Zip Surgical Skin Closure device
EXPERIMENTALThe Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check.
Standard Suture Closure
ACTIVE COMPARATORThe surgeon will perform standard suture closure for the skin layer following CIED procedure.
Interventions
The Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check.
The surgeon will perform standard suture closure for the skin layer following CIED procedure.
Eligibility Criteria
You may qualify if:
- Patients 18 years of age and older;
- Patients requiring suture closure for epidermal closure (after placement of cardiac implantable electronic devices; including de novo and re implant generator changes);
- Patients willing and able to complete study protocol
- Life expectancy greater than 1 year
You may not qualify if:
- Known bleeding disorder not caused by medication;
- Known personal or family history of keloid formation or scar hypertrophy;
- Known allergy or hypersensitivity to non-latex skin adhesives;
- Atrophic skin deemed clinically prone to blistering;
- Any skin disorder affecting wound healing;
- Any other condition that in the opinion of the investigator would make a particular subject unsuitable for this study.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- ZipLine Medical Inc.collaborator
Study Sites (1)
UCSD Sulpizio Cardiovascular Center
La Jolla, California, 92037, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ulrika Birgersdotter-Green, MD
- Organization
- UC San Diego School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Ulrika Birgersdotter-Green, MD
University of California, San Diego
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 7, 2014
First Posted
August 11, 2014
Study Start
August 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
May 30, 2016
Results First Posted
May 30, 2016
Record last verified: 2016-05